Printer Friendly

Articles from Journal of Commercial Biotechnology (October 1, 2012)

1-14 out of 14 article(s)
Title Author Type Words
Analyzing the broadening scope of patentability in the advancing field of biotechnology. Downing, Jessica Report 5056
Biomarketing strategy and tactics 101: Part III of III. Dogramatzis, Dimitris Report 6436
Biotechnology in Brazil: an industry overview. Zylberberg, Ezequiel; Zylberberg, Claudia; Oner, Asli Ceylan Report 5959
Blood supply and safety in the developing world: considerations for emerging markets. Riley, William; McCullough, Jeffry Report 4662
CROs in modern-day China. Ma, Steven S. Report 5105
Emerging markets and differential pricing policies: a question of global health? Class, James N. Report 2356
Global health diplomacy and management mechanisms of US-China public health collaborations in China: lessons for emerging markets. Brown, Matthew; Mackey, Tim K.; Liang, Bryan A. Report 4073
Globalization, evolution and emergence of direct-to-consumer advertising: are emerging markets the next pharmaceutical marketing frontier? Mackey, Tim K.; Liang, Bryan A. Report 4940
Lessons on emerging markets and global health. Fan, Victoria Y.; Liang, Bryan A. Report 1386
Not fully harmonized: differences in biotechnology patenting between Europe and the United States. Dorn, Brian R.; Birtle, Zoe Report 2295
The birth of a discipline: bioentrepreneurship. Meyers, Arlen Report 617
The Partnership for Safe Medicines--India: lessons for partnerships in emerging markets. Misra, Bejon Report 2484
The University of California, Davis, collaborative model for biotechnology education and training. Kjelstrom, Judith A.; Mcdonald, Karen; Hargadon, Andrew; Agatstein, Wilton; Arnold, Meg Report 7471
Tipping point: biosimilars, emerging markets, and public-private engagement to promote global health. Liang, Bryan A.; Mackey, Timothy Report 7046

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |